GGrantIndex
Sort

40,608 grants matching prostate cancer

The Impact of DNA Damage Repair Abnormalities in Prostate Cancer

$1,617,094
Kenneth Offit · Sloan-Kettering Inst Can Research · P01 · FY2024 · CA

PROSTATE CANCER RESEARCH PROGRAM CLINICAL CONSORTIUM AWARD: UWCCC CLINICAL RESEARCH SITE

$1,616,581
University Of Wisconsin System · · FY2009 · Department of Defense

Commercial Readiness for Direct-to-Digital Pathology

$1,615,322
Michael John Levene · Applikate Technologies, Inc. · R44 · FY2024 · CA

DEVELOPMENT OF RADIOLIGAND THERAPY TARGETING CD46 FOR TREATMENT OF METASTATIC PROSTATE CANCER

$1,615,001
Regents Of The University Of California, San Francisco, The · · FY2021 · Defense Health Agency

IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design

$1,614,069
Thomas Waldmann · Division Of Clinical Sciences - Nci · ZIA · FY2010 · CA

Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy

$1,614,069
Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2010 · CA

Interrogating Epigenetic Changes in Cancer Genomes

$1,613,665
Tim H.-M. Huang · Ohio State University · U54 · FY2011 · CA

Assessment of serum peptide profiling to detect cancer-specific patterns

$1,613,081
Paul Tempst · Sloan-Kettering Inst Can Research · U24 · FY2007 · CA

Signal Processing And Instrumentation Section

$1,612,175
Thomas J Pohida · Center For Information Technology · ZIA · FY2017 · CT

Physicians Health Study II: Prevention Trial of Vitamins

$1,611,803
Brigham And Women'S Hospital · R01 · FY2005 · CA

TARGETING THE MECHANISMS DRIVING DOUBLE-NEGATIVE BASAL LIKE PROSTATE CANCER

$1,610,999
University Of Washington · · FY2017 · Department of the Army

Anti-carcinogenic Activity Of Cox inhibitors and NAG-1

$1,610,260
Thomas Eling · National Institute Of Environmental Health Sciences · ZIA · FY2011 · ES

1/2 TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership

$1,608,811
Grace X Ma · Temple Univ Of The Commonwealth · U54 · FY2019 · CA

Molecular Profiling of Clinical Specimens

$1,607,934
Daniel Edelman · Division Of Basic Sciences - Nci · ZIC · FY2010 · CA

Preventing invasive prostate cancer

$1,607,348
Raymond C Bergan · University Of Nebraska Medical Center · R01 · FY2025 · CA

Comparative Biomedical Scientist Training Program

$1,607,144
Robert Simpson · Division Of Basic Sciences - Nci · ZIG · FY2018 · CA

The Partnership for Native American Cancer Prevention (1 OF 2)

$1,607,085
Jani Cheri Ingram · Northern Arizona University · U54 · FY2015 · CA

TEMPORAL EVOLUTION OF N-MYC SIGNALING AND EARLY TARGETING OF THE NEUROENDOCRINE PHENOTYPE IN PROSTATE CANCER

$1,606,988
Dana-Farber Cancer Institute, Inc. · · FY2017 · Defense Health Agency

Physicians' Health Study II: Prevention Trial of Vitamins

$1,606,928
J Michael Gaziano · Brigham And Women'S Hospital · R01 · FY2009 · CA

Prostate Cancer Bone Metastasis: Biology and Targeting

$1,606,847
Leland W. Chung · Cedars-Sinai Medical Center · P01 · FY2010 · CA

PROGNOSTIC PREDICTION MODEL FOR PROSTATE CANCER IN AFRICAN AMERICAN MEN

$1,606,582
Case Western Reserve University · · FY2019 · Defense Health Agency

T-cell Biofactories for targeting extracellular matrix

$1,606,207
Parijat Bhatnagar · Sri International · R33 · FY2020 · CA

Study of hereditary prostate cancer and human artificial chromosomes

$1,605,220
Vladimir Larionov · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Integrative Molecular Epidemiology of Human Cancer

$1,604,436
Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Prostate Cancer Susceptibility: The ICPCG Study

$1,604,043
Stephen Norman Thibodeau · Mayo Clinic Rochester · U01 · FY2014 · CA